Back to company

Speciallægeselskabet Callisen ApS: Financial statements 2024

CVR: 31364620

Speciallægeselskabet Callisen ApS (CVR 31364620) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 7,260,743 and a net result of DKK 3,559,058 compared with DKK 5,187,910 the year before. That is a decrease of 22.4% compared with the year before. Equity amounted to DKK 4,194,317. The solvency ratio was 19.3%. The company had 4 employees in the financial year.

Gross Profit
7,260,743 kr.
Profit/Loss
3,559,058 kr.
Equity
4,194,317 kr.
Total Assets
21,785,573 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-7.3 mio.3.6 mio.4.2 mio.4
2023-9.4 mio.5.2 mio.5.6 mio.3
2022-6 mio.2.2 mio.2.4 mio.2
2021-8.1 mio.5.1 mio.5.3 mio.2
2020-3.7 mio.2.2 mio.2.7 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Speciallægeselskabet Callisen ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About Speciallægeselskabet Callisen ApS

Speciallægeselskabet Callisen ApS is a Danish company of the type Anpartsselskab based in Viborg, founded in 2008. The company is registered under the industry Speciallægers aktiviteter. The management consists of Ali Kehler. The company is owned by Speciallægeholdingselskabet Medic ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK 10,518,082 and a net result of DKK 5,451,381 compared with DKK 3,559,058 the year before. Equity amounted to DKK 10,377,723.